Duke University, Bristol-Myers Squibb Collaborate to Provide Clinical Trial Data Transparency

Global biopharmaceutical company Bristol-Myers Squibb has partnered with Durham, N.C-based Duke (University) Clinical Research Institute to expand access to clinical trial information, encouraging a more transparent data sharing effort, according to a news release.

Advertisement

Researchers who meet pre-specified requirements can request clinical trial information from studies sponsored by Bristol-Myers Squibb and obtain an independent scientific review from DCRI, according to the news release.

Clinical trial information such as protocols, full clinical study reports and anonymous patient-level data will be made available.

“Bristol-Myers Squibb’s collaboration with DCRI reflects our commitment to providing broader, more timely access to important clinical trial information and serves as a catalyst to strengthening public confidence in medicines, advancing science and improving public health,” said Francis Cuss, MB BChir, executive vice president and chief scientific officer of Bristol-Myers Squibb, in the news release.

More Articles on Clinical Trials:

BBK Worldwide Unveils 2 New Apps for Clinical Trial Patient Engagement
Inside the One C. Diff Vaccine Focusing on Prevention, Not Treatment
6 Companies Developing C. Diff Solutions


Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.